MATTHEW MCCOY: Open Payments
NPI 1447965108 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 48 payments from 13 companies in 2025. Trend: 2023 $193 · 2024 $1,333 · 2025 $1,458
Food & beverage: $1,458
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $512 |
| ABBVIE INC. | 8 | $256 |
| Janssen Scientific Affairs, LLC | 2 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $159 |
| Madrigal Pharmaceuticals | 5 | $108 |
| Aimmune Therapeutics, Inc. | 4 | $70 |
| Ardelyx, Inc. | 2 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| PFIZER INC. | 1 | $29 |
| QOL Medical, LLC | 1 | $23 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, SKYRIZI, LINZESS, RINVOQ, VOWST, IBSRELA.
Industry payments across MS — which companies pay providers there.
